Abstract:Phosphorylation of tau at Ser (396, 404) (p-tau396,404) is one of the earliest phosphorylation events, and plasma p-tau396,404 level appears to be a potentially promising biomarker of Alzheimer's disease (AD). The low abundance and easy degradation of p-tau in the plasma make the lateral flow assay (LFA) a suitable choice for point-of-care detection of plasma p-tau396,404 levels. Herein, based on our screening of a pair of p-tau396,404-specific antibodies, we developed a colorimetric and surface-enhanced Raman scattering (SERS) dual-readout LFA for the rapid, highly sensitive, and robust detection of plasma p-tau396,404 levels. This LFA realized a detection limit of 60 pg/mL by the naked eye or 3.8 pg/mL by SERS without cross-reacting with other tau species. More importantly, LFA rapidly and accurately differentiated AD patients from healthy controls, suggesting that it has the potential for clinical point-of-care application in AD diagnosis. This dual-readout LFA has the advantages of simple operation, rapid, and ultra-sensitive detection, providing a new way for early AD diagnosis and intervention, especially in primary and community AD screening. Electronic supplementary material: Supplementary material (characterization of AuNPs and 4-MBA@AuNP probe; the optimal 4-MBA load for AuNPs; the optimal K2CO3 volumes for 4-MBA@AuNP-3G5 conjugates; the optimal 3G5 load for 4-MBA@AuNP conjugates; effect of NaCl concentration on 4-MBA@AuNP-3G5 stability; the linear curve of T-line color and SERS intensity versus different p-tau396,404 concentrations; the comparison of colorimetric-based LFA test results and the diagnosis results; Raman intensities and antibody activity of 4-MBA@AuNP-3G5 before and after storage; colorimetric intensity of dual-readout LFA detecting different concentrations of p-tau396,404 protein; sequence of synthesized peptides used in this study; information of the participants in this study; the information of antibodies used in this study) is available in the online version of this article at 10.1007/s12274-022-5354-4.

A Sensitive Colorimetric Strategy for Monitoring Cerebral Β-Amyloid Peptides in AD Based on Dual-Functionalized Gold Nanoplasmonic Particles

Visual and Fluorescent Assays for Selective Detection of Beta-Amyloid Oligomers Based on the Inner Filter Effect of Gold Nanoparticles on the Fluorescence of CdTe Quantum Dots.

Detection of Femtomolar Amyloid-β Peptides for Early-Stage Identification of Alzheimer's Amyloid-β Aggregation with Functionalized Gold Nanoparticles

Ultrasensitive Detection of Alzheimer’s Amyloids on a Plasmonic-Gold Platform

Antibody Modified-Silver Nanoparticles for Colorimetric Immuno Sensing of Aβ(1–40/1–42) Based on the Interaction Between Β-Amyloid and Cu2+

Alzheimer’s Disease Determination by a Dual Probe on Gold Nanourchins and Nanohorn Hybrids

A Novel Viscosity Sensitive Hemicyanine Fluorescent Dye for Real-Time Imaging of Amyloid-Β Aggregation

Colorimetric determination of amyloid-β peptide using MOF-derived nanozyme based on porous ZnO-Co3O4 nanocages

Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer's disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay

Electrochemical Detection Of Beta-Amyloid Peptides On Electrode Covered With N-Terminus-Specific Antibody Based On Electrocatalytic O-2 Reduction By A Beta(1-16)-Heme-Modified Gold Nanoparticles

Differential Detection of Amyloid Aggregates in Old Animals Using Gold Nanorods by Computerized Tomography: A Pharmacokinetic and Bioaccumulation Study

Electrochemical Analysis of Amyloid Plaques and ApoE4 with Chitosan-Coated Gold Nanostars for Alzheimer's Detection

A Gold Nanoparticle Based Colorimetric and Fluorescent Dual-Channel Probe for Acetylcholinesterase Detection and Inhibitor Screening

Sensitive dual-mode sensing platform for Amyloid β detection: Combining dual Z-scheme heterojunction enhanced photoelectrochemistry analysis and dual-wavelength ratiometric electrochemiluminescence strategy

Simultaneous Detection of Alzheimer's Biomarkers using a Visual Electrochemiluminescence Bipolar Array

Electrochemical sensitive detection of amyloid-β oligomer harnessing cellular prion protein on AuNPs embedded poly (pyrrole-3-carboxylic acid) matrix

Electrochemical Detection of Amyloid-β Oligomers Based on the Signal Amplification of a Network of Silver Nanoparticles.

Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer's β-Amyloid

Ultrasensitive dual-mode detection of amyloid β oligomer via Au NRs modulated photoelectrochemical/electrochemiluminescent response from HOFs/g-C 3 N 4

Hybridization chain reaction triggered poly adenine to absorb silver nanoparticles for label-free electrochemical detection of Alzheimer's disease biomarkers amyloid β-peptide oligomers

Visualizing Aβ Deposits in Live Young AD Model Mice with a Simple Red/near-Infrared-fluorescent AIEgen